Medical/Pharmaceuticals News & Press Release Distribution

InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine Characterization

BOULDER, Colo., July 1, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Polio D-antigen quantification kit for r...

2021-07-01 15:00 1353

Elliott Publishes Letter on GlaxoSmithKline

Elliott believes GSK has a substantial value creation opportunity – 45% upside in its share price – ahead of Consumer Health separation and greater beyond Despite its strengths, GSK has a poor record of operational execution and value creation, leading to scepticism about the Company's future, an...

2021-07-01 14:45 1539

Elliott Publishes Letter on GlaxoSmithKline

Joint Commission International publishes fourth edition of International Accreditation Standards for Laboratories

Standards and policies in latest edition become effective 1 January 2022 OAK BROOK, Ill., July 1, 2021 /PRNewswire/ -- Joint Commission International (JCI) today publishedJoint Commission International Accreditation Standards for Laboratories, Fourth Edition. The manual provides requirements for ...

2021-07-01 08:00 1068

European Wellness partners with China's provincial government to advance Education in Biological Regenerative Medicine

EDENKOBEN, Germany, July 1, 2021 /PRNewswire/ – European Wellness Biomedical Group (European Wellness) through its educational arm, European Wellness Academy (EWA), has signed a Letter of Intent (LOI) withZhifu People's Government of Yantai City,Shandong Province, China to establish the first In...

2021-07-01 08:00 3121

European Wellness partners with China's provincial government to advance Education in Biological Regenerative Medicine

Joint Commission International publishes fourth edition of International Accreditation Standards for Laboratories

Standards and policies in latest edition become effective 1 January 2022 OAK BROOK, Ill., July 1, 2021 /PRNewswire/ -- Joint Commission International (JCI) today publishedJoint Commission International Accreditation Standards for Laboratories, Fourth Edition. The manual provides requirements for ...

2021-07-01 08:00 1167

Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints

SINGAPORE, July 1, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a partnership with OSSIS to serve as the exclusiveAsia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints. ...

2021-07-01 08:00 3775

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

SYDNEY, June 30, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to provide an update on recent progress with its two pipeline assets, paxalisib and EVT801. Key Points * GBM AGILE pivotal study of paxalisib is...

2021-06-30 22:00 30027

VUNO Inks Deal with Samsung Electronics to Embed AI-powered Algorithms in Samsung's Premium Mobile X-ray System

SEOUL, South Korea, June 30, 2021 /PRNewswire/ -- South Korean artificial intelligence (AI) developer, VUNO Inc., announced today a partnership with Samsung Electronics Co., Ltd., global medical device company to incorporate its AI-powered chest X-ray diagnostic solution, VUNO Med®-Chest X-ray™, ...

2021-06-30 21:00 1250

VUNO Inks Deal with Samsung Electronics to Embed AI-powered Algorithms in Samsung's Premium Mobile X-ray System

I-Mab Honored with Top Rankings by Institutional Investor

SHANGHAI and GAITHERSBURG, Md., June 30, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it was ranked among the top companies by leading gl...

2021-06-30 20:00 12449

Antheia Announces $73M Series B to Commercialize Synthetic Biology Platform for Essential Medicines

Led by Viking Global Investors, the Series B round will be used to bring Antheia's first pharmaceutical compounds to market, expand its pipeline and scale production in global markets MENLO PARK, Calif., June 30, 2021 /PRNewswire/ -- Antheia, a synthetic biology company enabling next-generation ...

2021-06-30 20:00 1549

Mentice receives order of total SEK 5.9 million from Baylis Medical Company

STOCKHOLM, June 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on interventional procedures, has entered into an agreement withBaylis Medical Company ("Baylis")to provide simulation solutions. Based on t...

2021-06-30 18:19 1163

Akeso Awarded as 2021 "Most Honored Company" by Institutional Investor

HONG KONG, June 30, 2021 /PRNewswire/ -- Akeso, Inc. ("Akeso" or the "Company", stock code: 9926.HK) is pleased to announce today that, Akesohas been awarded as "Most Honored Company" in the "2021 All-Asia Executive Team" survey published byInstitutional Investor, and has been ranked top 3 in all...

2021-06-30 16:00 13052

Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate

* Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum) * Pending conditional regulatory approvals, Clover expects to commence product launch of SCB-2019 (CpG 1018/Alum) by the end of 2021 CHENGDU,...

2021-06-30 16:00 4174

Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility

* Pending WHO EUL for its COVID-19 vaccine candidate, Clover is committed to providing 64 million doses in 2021 and Gavi has options for an additional 350 million doses in 2022 * Clover will receive a significant upfront payment, a payment upon positive Phase 2/3 data, potential payments upon...

2021-06-30 16:00 1957

Mentice appoints Gunilla Andersson as Chief Financial Officer (CFO)

STOCKHOLM, June 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on image guided interventions,appoints Gunilla Andersson as CFO, effective September 1st, 2021. Mentice AB is pleased to announce the appoin...

2021-06-30 15:06 1292

Envirotainer Greets China Airlines as the latest airline to approve the new Releye® RLP container

STOCKHOLM, June 30, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that China Airlines has approved the Envirotainer Releye® RLP for usage on their aircrafts. With this approval, China Airlines ...

2021-06-30 14:48 1639

Bioinduction Announces the World's First Successful Implantations of 'PICOSTIM', a Novel, Less Invasive, Self-Contained Cranialized 'Brain Pacemaker' for Parkinson's Disease

Small, smart, single-stage skull implanted DBS system can be implanted in under half the time of conventional implantations BRISTOL, England, June 30, 2021 /PRNewswire/ -- Bioinduction Ltd., a company developing an innovative and disruptive patient-centric Deep Brain Stimulation (DBS) platform s...

2021-06-30 14:00 1121

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

NEW YORK, June 29, 2021 /PRNewswire/ -- OnCusp Therapeutics (or "OnCusp"), a global biopharmaceutical company focused on translating cutting-edge research assets into innovative oncology therapeutics, announced that it has officially commenced operations both inNew York and Shanghai. OnCusp succ...

2021-06-30 09:29 1282

New Welch Allyn® PanOptic™ Plus Ophthalmoscope and Welch Allyn® MacroView® Plus Otoscope Give Caregivers Better, Bolder, Brighter Views

SINGAPORE, June 30, 2021 /PRNewswire/ -- Hillrom today announced major technological advances to its market-leading physical assessment tools with the launch of the new Welch Allyn® PanOptic™ Plus Ophthalmoscope and the Welch Allyn® MacroView® Plus Otoscope. The new devices represent advancements...

2021-06-30 09:15 3552

New Welch Allyn® PanOptic™ Plus Ophthalmoscope and Welch Allyn® MacroView® Plus Otoscope Give Caregivers Better, Bolder, Brighter Views

Subcutaneously Injected PD-L1 Antibody Envafolimab (KN035) Obtained Its Second Orphan Drug Designation From The U.S. FDA

SUZHOU, China, June 30, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to envafolimab (KN035), a recombinant humanized PD-L1 single-domain antibody independently invented by Alphamab Onco...

2021-06-30 08:55 8370